نتایج جستجو برای: ppar γ

تعداد نتایج: 81065  

2014
Guoda Ma Haiyang Wang Guixi Mo Lili Cui You Li Yiming Shao Xin Liu Yuliu Xie Jia Li Jiawu Fu Hua Tao Bin Zhao Liangqing Zhang Keshen Li

Peroxisome proliferator-activated receptor-γ (PPAR-γ) is a ligand-binding nuclear receptor, and its activation plays a prominent role in regulating the inflammatory response. Therefore, PPAR-γ has been suggested as a candidate gene for sepsis. In the present study, we investigated the association between the Pro12Ala polymorphism of PPAR-γ and sepsis in a Han Chinese population. A total of 308 ...

Journal: :Molecular pharmacology 2011
Yasser Majeed Yahya Bahnasi Victoria A L Seymour Lesley A Wilson Carol J Milligan Anil K Agarwal Piruthivi Sukumar Jacqueline Naylor David J Beech

The aim of this study was to generate new insight into chemical regulation of transient receptor potential (TRP) channels with relevance to glucose homeostasis and the metabolic syndrome. Human TRP melastatin 2 (TRPM2), TRPM3, and TRP canonical 5 (TRPC5) were conditionally overexpressed in human embryonic kidney 293 cells and studied by using calcium-measurement and patch-clamp techniques. Rosi...

Journal: :Investigative ophthalmology & visual science 2017
Selikem Abla Nuwormegbe Joon Hyung Sohn Sun Woong Kim

Purpose Fibroblast activation may play an important role in pterygium progression. Synthetic peroxisome proliferator-activated receptor γ (PPAR-γ) ligands have been shown to be effective antifibrotic agents against transforming growth factor β1 (TGF-β1) induced fibrosis in several tissues. We aimed to investigate the antifibrotic effects of the PPAR-γ ligand rosiglitazone in pterygium fibroblas...

2012
Renée Deehan Pia Maerz-Weiss Natalie L. Catlett Guido Steiner Ben Wong Matthew B. Wright Gil Blander Keith O. Elliston William Ladd Maria Bobadilla Jacques Mizrahi Carolina Haefliger Alan Edgar

AIMS To compare the molecular and biologic signatures of a balanced dual peroxisome proliferator-activated receptor (PPAR)-α/γ agonist, aleglitazar, with tesaglitazar (a dual PPAR-α/γ agonist) or a combination of pioglitazone (Pio; PPAR-γ agonist) and fenofibrate (Feno; PPAR-α agonist) in human hepatocytes. METHODS AND RESULTS Gene expression microarray profiles were obtained from primary hum...

Journal: :DNP - Der Neurologe & Psychiater 2017

2003
R. Lupi S. Del Guerra L. Marselli M. Bugliani U. Boggi F. Mosca P. Marchetti S. Del Prato

Peroxisome proliferator-activated receptors (PPARs) are a subgroup of the superfamily of nuclear receptors, with three distinct main types: α, β and γ (subdivided into γ 1 and γ 2). Recently, the presence of PPARs-γ has been reported in human islets. Whether the other PPARs types can be found in human islets, how islet PPAR-γ mRNA expression is regulated by the metabolic milieu, their role in i...

Journal: :Journal of Biological & Scientific Opinion 2013

2012
D. Ortuño Sahagún A. L. Márquez-Aguirre S. Quintero-Fabián R. I. López-Roa A. E. Rojas-Mayorquín

A direct correlation between adequate nutrition and health is a universally accepted truth. The Western lifestyle, with a high intake of simple sugars, saturated fat, and physical inactivity, promotes pathologic conditions. The main adverse consequences range from cardiovascular disease, type 2 diabetes, and metabolic syndrome to several cancers. Dietary components influence tissue homeostasis ...

2014
Yang Long Xiang-Xun Zhang Tao Chen Yun Gao Hao-Ming Tian

Increased levels of free fatty acids (FFAs) and hypertriglyceridemia are important risk factors for cardiovascular disease. The effective fraction isolated from radix astragali (RA) has been reported to alleviate hypertriglyceridemia. The mechanism of this triglyceride-lowering effect of RA is unclear. Here, we tested whether activation of the mTORC1-PPAR γ signaling pathway is related to the t...

2009
Masahide Matsuyama Rikio Yoshimura

Recent epidemiological studies and animal experiments have demonstrated that nonsteroidal anti-inflammatory drugs (NSAIDs) reduce the incidence of colorectal carcinoma. Cyclooxygenase (COX) is the principal target of NSAIDs. COX is the first oxidase in the process of prostaglandin production from arachidonic acid. COX enzyme may be involved in the initiation and/or the promotion of tumorigenesi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید